Search by First Name and/or Last Name. Results are displayed in descending publication year and then sorted ascending by the reference field. Need to submit a publication reference?


Researcher Publication Search Form

Name: Anne Fagan
Year: 2017

Reference:

Millar PR, Balota DA, Maddox GB, Duchek JM, Aschenbrenner AJ, Fagan AM, Benzinger TL, Morris JC. Process Dissociation Analyses of Memory Changes in Healthy Aging, Preclinical, and Very Mild Alzheimer Disease: Evidence for Isolated Recollection Deficits. Neuropsychology. 2017 Feb 16. NIHMS ID: NIHMS841051

Name: Peter Millar
Year: 2017

Reference:

Millar, PR, Balota, DA, Maddox, GB, Duchek, JM, Aschenbrenner, AJ, Fagan, AM, Benzinger, TLS, & Morris, JC (2017). Process dissociation analyses of memory changes in healthy aging, preclinical, and very mild Alzheimer disease: Evidence for isolated recollection deficits. Neuropsychology, 31 (7), 708-723. DOI: 10.1037/neu0000352 PMCID: PMC5559353 PMID: 28206782.

Name: Tammie Benzinger
Year: 2017

Reference:

Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels.
Babulal GM, Ghoshal N, Head D, Vernon EK, Holtzman DM, Benzinger TL, Fagan AM, Morris JC, Roe CM.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 2016; 24(11):1095-1104. NIHMSID: NIHMS779564
PubMed [journal]PMID: 27426238 PMCID: PMC5069099

Name: Jeffrey Zacks
Year: 2017

Reference:

Richmond, L. L., Gold, D. A., & Zacks, J. M. (in press). Improving event cognition: From the laboratory to the clinic. Journal of Applied Research in Memory and Cognition.

Name: Anne Fagan
Year: 2017

Reference:

Ringman JM, Casado M, Van Berlo V, Pa J, Joseph-Mathurin N, Fagan AM, Benzinger T, Bateman RJ, Morris JC. A novel PSEN1 (S230N) mutation causing early-onset Alzheimer’s Disease associated with prosopagnosia, hoarding, and Parkinsonism. Neurosci Lett. 2017 Jul 29;657:11-15. PMID: 28764909

Name: Anne Fagan
Year: 2017

Reference:

Roe CM, Babulal GM, Head DM, Stout SH, Vernon EK, Ghoshal N, Garland B, Barco PP, Williams MM, Johnson A, Fierberg R , Fague MS, Xiong C, Mormino E10, Grant EA, Holtzman DM, Benzinger TLS, Fagan AM, Ott BR, Carr DB, Morris JC. Preclinical Alzheimer’s disease and longitudinal driving decline. Alzheimers Dement (N Y). 2017 Jan, 3(1):74-82. PMCID: PMC5396459

Name: Suzanne Schindler
Year: 2017

Reference:

Schindler SE, Jasielec MS, Weng H, Hassenstab JJ, Grober E, McCue LM, Morris JC, Holtzman DM, Xiong C, Fagan AM. Neuropsychological measures that detect early impairment and decline in preclinical Alzheimer disease. Neurobiol Aging 2017; 56:25-32. PMID: 28482211.

Name: Brian Gordon
Year: 2017

Reference:

Shruti, M, Gordon BA, Su, Y, Christensen, J, Friedrichsen, K, Jackson K, Hornbeck, R, Balota DM, Cairns, N, Ances, B, Morris, JC. Benzinger TLS (2017). Tau PET imaging in preclinical Alzheimer’s Disease: Classifying tau Positivity. NeuroImage. 161, 171-178

Name: Jason Ulrich
Year: 2017

Reference:

Susanne Krasemann, Charlotte Madore, Ron Cialic, Caroline Baufeld, Narghes Calcagno, Rachid El Fatimy, Lien Beckers, Elaine O’Loughlin, Yang Xu, Zain Fanek, David J. Greco, Scott T. Smith, George Tweet, Zachary Humulock, Tobias Zrzavy, Patricia Conde-Sanroman, Mar Gacias, Zhiping Weng, Hao Chen, Emily Tjon, Fargol Mazaheri, Kristin Hartmann, Asaf Madi, Jason D. Ulrich, Markus Glatzel, Anna Worthmann, Joerg Heeren, Bogdan Budnik, Cynthia Lemere, Tsuneya Ikezu, Frank L. Heppner, Vladimir Litvak, David M. Holtzman, Hans Lassmann, Howard L. Weiner, Jordi Ochando, Christian Haass, Oleg Butovsky, The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases, Immunity, Volume 47, Issue 3, 19 September 2017, Pages 566-581.e9, ISSN 1074-7613, https://doi.org/10.1016/j.immuni.2017.08.008.

Name: Nigel Cairns
Year: 2017

Reference:

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D,
Jack CR Jr, Jagust W, Morris JC, Petersen RC, Salazar J, Saykin AJ, Shaw LM, Toga
AW, Trojanowski JQ; Alzheimer’s Disease Neuroimaging Initiative. The Alzheimer’s
Disease Neuroimaging Initiative 3: Continued innovation for clinical trial
improvement. Alzheimers Dement. 2017 May;13(5):561-571. doi:
10.1016/j.jalz.2016.10.006. Epub 2016 Dec 5. Review. PubMed PMID: 27931796.

Name: Nigel Cairns
Year: 2017

Reference:

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D,
Jack CR Jr, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw LM, Toga AW,
Trojanowski JQ; Alzheimer’s Disease Neuroimaging Initiative. Recent publications
from the Alzheimer’s Disease Neuroimaging Initiative: Reviewing progress toward
improved AD clinical trials. Alzheimers Dement. 2017 Apr;13(4):e1-e85. doi:
10.1016/j.jalz.2016.11.007. Epub 2017 Mar 22. Review. PubMed PMID: 28342697.

Name: Nigel Cairns
Year: 2017

Reference:

Yanamandra K, Patel TK, Jiang H, Schindler S, Ulrich JD, Boxer AL, Miller BL,
Kerwin DR, Gallardo G, Stewart F, Finn MB, Cairns NJ, Verghese PB, Fogelman I,
West T, Braunstein J, Robinson G, Keyser J, Roh J, Knapik SS, Hu Y, Holtzman DM.
Anti-tau antibody administration increases plasma tau in transgenic mice and
patients with tauopathy. Sci Transl Med. 2017 Apr 19;9(386). pii: eaal2029. doi:
10.1126/scitranslmed.aal2029. PubMed PMID: 28424326.

Name: Nigel Cairns
Year: 2017

Reference:

Yanamandra K, Patel TK, Jiang H, Schindler S, Ulrich JD, Boxer AL, Miller BL,
Kerwin DR, Gallardo G, Stewart F, Finn MB, Cairns NJ, Verghese PB, Fogelman I,
West T, Braunstein J, Robinson G, Keyser J, Roh J, Knapik SS, Hu Y, Holtzman DM.
Anti-tau antibody administration increases plasma tau in transgenic mice and
patients with tauopathy. Sci Transl Med. 2017 Apr 19;9(386). pii: eaal2029. doi:
10.1126/scitranslmed.aal2029. PubMed PMID: 28424326.

Name: Nigel Cairns
Year: 2017

Reference:

Zhao Y, Raichle ME, Wen J, Benzinger TL, Fagan AM, Hassenstab J, Vlassenko AG,
Luo J, Cairns NJ, Christensen JJ, Morris JC, Yablonskiy DA. In vivo detection of
microstructural correlates of brain pathology in preclinical and early Alzheimer
Disease with magnetic resonance imaging. Neuroimage. 2017 Mar 1;148:296-304. doi:
10.1016/j.neuroimage.2016.12.026. Epub 2016 Dec 15. PubMed PMID: 27989773; PubMed
Central PMCID: PMC5344724.

Name: Gregory Day
Year: 2016

Reference:

A Case Study in the History of Neurology.

Day GS, Tang-Wai DF, Shamy MC.

Neurohospitalist. 2016 Oct;6(4):181-184.

PMID: 27695602

Name: Anne Fagan
Year: 2016

Reference:

Allison SL, Fagan AM, Morris JC, Head D. Spatial Navigation in Preclinical Alzheimer’s Disease.J Alzheimers Dis. 2016 Feb 9. [Epub ahead of print]

Name: Tammie Benzinger
Year: 2016

Reference:

Amyloid Imaging, Cerebrospinal Fluid Biomarkers Predict Driving Performance Among Cognitively Normal Individuals.
Roe CM, Barco PP, Head DM, Ghoshal N, Selsor N, Babulal GM, Fierberg R, Vernon EK, Shulman N, Johnson A, Fague S, Xiong C, Grant EA, Campbell A, Ott BR, Holtzman DM, Benzinger TL, Fagan AM, Carr DB, Morris JC.
Alzheimer disease and associated disorders. 2016; NIHMSID: NIHMS767136
PubMed [journal]PMID: 27128959 PMCID: PMC5085874

Name: Gregory Day
Year: 2016

Reference:

Anti N-methyl-D-aspartate receptor encephalitis: a game-changer?

Fischer CE, Golas AC, Schweizer TA, Munoz DG, Ismail Z, Qian W, Tang-Wai DF, Rotstein DL, Day GS.

Expert Rev Neurother. 2016 Jul;16(7):849-59. doi: 10.1080/14737175.2016.1184088.

PMID: 27123777

Name: Gregory Day
Year: 2016

Reference:

Anti N-methyl-D-aspartate receptor encephalitis: a game-changer?

Fischer CE, Golas AC, Schweizer TA, Munoz DG, Ismail Z, Qian W, Tang-Wai DF, Rotstein DL, Day GS.

Expert Rev Neurother. 2016 Jul;16(7):849-59. doi: 10.1080/14737175.2016.1184088. Epub 2016 May 17.

PMID: 27123777

Name: Nigel Cairns
Year: 2016

Reference:

Armstrong RA, McKee AC, Stein TD, Alvarez VE, Cairns NJ.A quantitative study of tau pathology in eleven cases of chronic traumatic encephalopathy.Neuropathol Appl Neurobiol. 2016 Mar 21

Name: david balota
Year: 2016

Reference:

Aschenbrenner AJ, Balota DA, Gordon BA, Ratcliff R, Morris JC. A diffusion model analysis of episodic recognition in individuals with a family history of Alzheimer disease: The Adult Children Study. Neuropsychology 2016; 30: 225-238. PMCID: PMC4720576.

Name: Ganesh Babulal
Year: 2016

Reference:

Babulal GM, Addison A, Ghoshal N, Stout SH, Vernon EK, Sellan M, Roe CM. Development and interval testing of a naturalistic driving methodology to evaluate driving behavior in clinical research. F1000Research. 2016; 5:1716 (doi: 10.12688/f1000research.9150.2)

Name: Anne Fagan
Year: 2016

Reference:

Babulal GM, Ghoshal N, Head D, Vernon EK, Holtzman DM, Benzinger TL, Fagan AM, Morris JC, Roe CM. Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer’s Disease Biomarker Levels. The American Journal of Geriatric Psychiatry. 2016 Apr 19 (in press).

Name: Ganesh Babulal
Year: 2016

Reference:

Babulal GM, Ghoshal N, Head D, Vernon EK, Holtzman DM, Benzinger TLS, Fagan AM, Morris JC, Roe CM. Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels. The American Journal of Geriatric Psychiatry.24(11):1095-104. doi: 10.1016/j.jagp.2016.04.004. PMID: 27426238

Name: Ganesh Babulal
Year: 2016

Reference:

Babulal GM, Traub CM, Webb M, Stout SH, Addison A, Carr DB, Ott BR, Morris JC, Roe CM. Creating a driving profile for older adults using GPS devices and naturalistic driving methodology. F1000Research. 2016;5.